Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_assertion type Assertion NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_head.
- NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_assertion wasGeneratedBy ECO_0000203 NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_provenance.
- NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_assertion wasDerivedFrom befree-20140225 NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_provenance.
- NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_assertion SIO_000772 15547699 NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_provenance.
- NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_assertion evidence source_evidence_literature NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_provenance.
- NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_assertion description "[In order to understand if metastatic breast cancer lesions might be associated with a defective proteasome subunit expression that, in turn, might limit the peptide availability and prevent stable cell surface HLA class I-tumor antigen expression, we studied by immunostaining the expression of beta2-microglobulin, HLA class I antigens and proteasome subunits LMP-2 and LMP-10 in 35 matched primary and metastatic human breast carcinoma lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189341.RABc4sTR0fjwnntAtMw0uhgt9mqGrjkk1ycf5h38zyezg130_provenance.